NOVOCURE LTD (NVCR) — large price moves

Health Care · NASDAQ

Single sessions where NVCR closed 10% or more away from the previous close, between 2025-10-08 and 2026-10-08. Each one lists the events filed in the 5 days ending at that session, in date order.

← NVCR profile NVCR filings Ask about NVCR →

Of the 9 moves listed, 4 have at least one filed event in the 5 days ending at the session, and 5 have none. Across the catalog most large moves have nothing filed near them, so an empty list is an ordinary result and not a gap.

Moves

2026-07-24 -11.7% $19.99 to $17.65 filed events in the 5 days to 2026-07-24
- 2026-07-23 Earnings Quarterly results reportedquarter ended 2026-06-30 · reported EPS USD -0.13 against an estimate of USD -0.33 · surprise +60.8%Source: SEC filing calendar + Yahoo earnings history
- 2026-07-23 Periodic filing 10-Q filedaccession 0001645113-26-000062Source: SEC EDGAR
- 2026-07-23 Material event 8-K filed (material event)accession 0001645113-26-000063Source: SEC EDGAR
2026-07-23 +28.4% $15.57 to $19.99 filed events in the 5 days to 2026-07-23
- 2026-07-23 Earnings Quarterly results reportedquarter ended 2026-06-30 · reported EPS USD -0.13 against an estimate of USD -0.33 · surprise +60.8%Source: SEC filing calendar + Yahoo earnings history
- 2026-07-23 Periodic filing 10-Q filedaccession 0001645113-26-000062Source: SEC EDGAR
- 2026-07-23 Material event 8-K filed (material event)accession 0001645113-26-000063Source: SEC EDGAR
2026-06-18 -20.0% $17.85 to $14.28 filed events in the 5 days to 2026-06-18

No filed event was recorded for this company in the 5 days ending on this session. That is what our sources hold, not a statement about what happened.
2026-06-04 +11.4% $16.15 to $17.99 filed events in the 5 days to 2026-06-04
- 2026-06-02 Insider trade Open-market sale reported by an insider7 transactions · 7 insiders · $325,113Source: SEC Form 4
- 2026-06-04 Insider trade Open-market sale reported by an insider1 transaction · 1 insider · $614,635Source: SEC Form 4
2026-04-30 +27.5% $11.93 to $15.21 filed events in the 5 days to 2026-04-30
- 2026-04-30 Earnings Quarterly results reportedquarter ended 2026-03-31 · reported EPS USD -0.62 against an estimate of USD -0.51 · surprise -20.9%Source: SEC filing calendar + Yahoo earnings history
- 2026-04-30 Periodic filing 10-Q filedaccession 0001645113-26-000042Source: SEC EDGAR
- 2026-04-30 Material event 8-K filed (material event)accession 0001645113-26-000043Source: SEC EDGAR
- 2026-04-30 Filing language mdna changed in the 10-Qsection mdna · accession 0001645113-26-000042Source: SEC EDGAR (section comparison against the prior filing)
2026-02-25 +27.7% $11.74 to $14.99 filed events in the 5 days to 2026-02-25

No filed event was recorded for this company in the 5 days ending on this session. That is what our sources hold, not a statement about what happened.
2026-02-13 -12.3% $12.53 to $10.99 filed events in the 5 days to 2026-02-13

No filed event was recorded for this company in the 5 days ending on this session. That is what our sources hold, not a statement about what happened.
2026-02-12 +19.3% $10.50 to $12.53 filed events in the 5 days to 2026-02-12

No filed event was recorded for this company in the 5 days ending on this session. That is what our sources hold, not a statement about what happened.
2026-02-05 -12.7% $11.56 to $10.09 filed events in the 5 days to 2026-02-05

No filed event was recorded for this company in the 5 days ending on this session. That is what our sources hold, not a statement about what happened.

These are events filed near a session, listed by date. They are not ranked, and no connection between an event and a price move is stated or implied.

Ask the chat about NVCR's filings →

See the full company profile: NOVOCURE LTD (NVCR).

Informational only — NOT financial advice. Price moves are computed from stored daily closes; filed events come from their own sources with their own dates.